Patent Assignment
Reel/Frame 064419/0493
Security Interest
Recorded: 2023-07-28
Pages: 11
Assignee
NOVAQUEST CO-INVESTMENT FUND XV, L.P.
4208 SIX FORKS ROAD, SUITE 920, RALEIGH, NORTH CAROLINA, 27609
Covered Properties
(45)
Methods of Treating Bacterial Infections Through Pulmonary Delivery of Fusidic Acid
Application:
13/819,917 →
Publication:
US US20130164351A1
Methods of Treating Bacterial Infections Through Pulmonary Delivery of Fusidic Acid
Application:
61/378,032 →
Compositions Comprising Fusidic Acid and Packages Therefor
Application:
61/489,017 →
Compositions and Methods for Treating Bone and Joint Infections
Application:
62/011,215 →
Compositions and Methods for Treating Bone and Joint Infections
Application:
15/317,578 →
Publication:
US US20170119793A1
Compositions and Methods for Treating Bone and Joint Infections
Application:
16/278,956 →
Publication:
US US20190388437A1
Compositions Comprising Fusidic Acid and Packages Therefor
Application:
17/466,366 →
Publication:
US US20220233699A1
Use of a TLR9 Agonist in Methods for Treating Covid-19
Application:
17/226,866 →
Publication:
US US20210317454A1
Fusidic Acid Dosing Regimens for Treatment of Bacterial Infections
Methods of Treating Urethritis and Related Infections Using Fusidic Acid
Modulation of Immunostimulatory Properties of Oligonucleotide-Based Compounds by Optimal Presentation of 5' Ends
Modulation of Immunostimulatory Activity of Immunostimulatory Oligonucleotide Analogs by Positional Chemical Changes
Modulation of Immunostimulatory Activity of Immunostimulatory Oligonucleotide Analogs by Positional Chemical Changes
Stabilized Immunomodulatory Oligonucleotides
Stabilized Immunomodulatory Oligonucleotides
Patent:
8,946,175 →
Application:
13/210,903 →
Immunostimulatory Oligonucleotide Multimers
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
Immune Regulatory Oligonucleotide (Iro) Compounds to Modulate Toll-Like Receptor Based Immune Response
Immune Regulatory Oligonucleotide (Iro) Compounds to Modulate Toll-Like Receptor Based Immune Response
Immune Regulatory Oligonucleotide (Iro) Compounds to Modulate Toll-Like Receptor Based Immune Response
Immune Regulatory Oligonucleotide (Iro) Compounds to Modulate Toll-Like Receptor Based Immune Response
Immune Regulatory Oligonucleotide (Iro) Compounds to Modulate Toll-Like Receptor Based Immune Response
Immune Regulatory Oligonucleotide (Iro) Compounds to Modulate Toll-Like Receptor Based Immune Response
Stabilized Immune Modulatory Rna (Simra) Compounds for TLR7 and TLR8
Stabilized Immune Modulatory Rna (Simra) Compounds for TLR7 and TLR8
Stabilized Immune Modulatory Rna (Simra) Compounds for TLR7 and TLR8
Toll Like Receptor Modulators
Novel Synthetic Agonists of TLR9
Use of Inhibitors of Toll-Like Receptors in the Prevention and Treatment of Hypercholesterolemia and Hyperlipidemia and Diseases Related Thereto
Potentiation of Autoimmune and Inflammatory Disease Treatments by Immune Regulatory Oligonucleotide (Iro) Antagonists of TLR7 and TLR9
Compositions for Inhibiting Gene Expression and Uses Thereof
Patent:
8,431,544 →
Application:
12/869,209 →
Novel Agonists of Toll-Like Receptor 3 and Methods of Their Use
Immune Regulatory Oligonucleotide (Iro) Compounds to Modulate Toll-Like Receptor Based Immune Response
Immune Regulatory Oligonucleotide (Iro) Compounds to Modulate Toll-Like Receptor Based Immune Response
Immune Regulatory Oligonucleotide (Iro) Compounds to Modulate Toll-Like Receptor Based Immune Response
Compositions for Inhibiting Gene Expression and Uses Thereof
Immune Regulatory Oligonucleotide (Iro) Compounds to Modulate Toll-Like Receptor Based Immune Response
Immune Regulatory Oligonucleotide (Iro) Compounds to Modulate Toll-Like Receptor Based Immune Response
Immune Regulatory Oligonucleotide (Iro) Compounds to Modulate Toll-Like Receptor Based Immune Response
Toll-Like Receptor 9 Antagonist and Methods of Use Thereof
Compositions for Inhibiting Checkpoint Gene Expression and Uses Thereof
Fusidic Acid Dosing Regimens for Treatment of Bacterial Infections
PCT:
PCT/US2009/050353 ↗
Methods of Treating Bacterial Infections Through Pulmonary Delivery of Fusidic Acid
PCT:
PCT/US2011/047771 ↗
Compositions Comprising Fusidic Acid and Packages Therefor
PCT:
PCT/US2012/039219 ↗
Compositions and Methods for Treating Bone and Joint Infections
PCT:
PCT/US2015/035596 ↗
Related Assignments
(19)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 14, 2014
From: KANDIMALLA, EKAMBAR R.; BHAGAT, LAKSHMI; PANDEY, RAJENDRA K.; YU, DONG
To: HYBRIDON, INC.
Reel/Frame 033305/0919 →
Merger
Jul 14, 2014
From: HYBRIDON, INC.; IDERA PHARMACEUTICALS, INC.
To: IDERA PHARMACEUTICALS, INC.
Reel/Frame 033318/0675 →
Assignment of Assignor's Interest
Sep 3, 2014
From: FERNANDES, PRABHAVATHI
To: CEM-102 PHARMACEUTICALS, INC.
Reel/Frame 033655/0770 →
Assignment of Assignor's Interest
Jul 22, 2015
From: FERNANDES, PRABHAVATHI
To: CEM-102 PHARMACEUTICALS, INC.
Reel/Frame 036150/0067 →
Security Interest
Jan 8, 2018
From: MELINTA THERAPEUTICS, INC.; REMPEX PHARMACEUTICALS, INC.; CEMPRA PHARMACEUTICALS, INC.; CEM-102 PHARMACEUTICALS, INC.
To: CORTLAND CAPITAL MARKET SERVICES LLC, AS AGENT
Reel/Frame 045019/0552 →
Release of Security Interest
Jan 10, 2019
From: CORTLAND CAPITAL MARKET SERVICES LLC, AS AGENT
To: MELINTA THERAPEUTICS, INC.; REMPEX PHARMACEUTICALS, INC.; CEMPRA PHARMACEUTICALS, INC.; CEM-102 PHARMACEUTICALS, INC.
Reel/Frame 047949/0754 →
Assignment of Assignor's Interest
Jan 12, 2019
From: CEM-102 PHARMACEUTICALS, INC.
To: ARREVUS, INC.
Reel/Frame 047978/0929 →
Assignment of Assignor's Interest
Jan 12, 2019
From: CEMPRA PHARMACEUTICALS, INC.
To: ARREVUS, INC.
Reel/Frame 047978/0933 →
Security Agreement
May 14, 2021
From: DELL PRODUCTS L.P.; EMC IP HOLDING COMPANY LLC
To: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
Reel/Frame 056250/0541 →
Corrective Assignment to Correct the Missing Patents That Were on the Original Scheduled Submitted but Not Entered Previously Recorded at Reel: 056250 Frame: 0541. Assignor(S) Hereby Confirms the Assignment.
May 17, 2021
From: DELL PRODUCTS L.P.; EMC IP HOLDING COMPANY LLC
To: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
Reel/Frame 056311/0781 →
Security Interest
May 19, 2021
From: DELL PRODUCTS L.P.; EMC IP HOLDING COMPANY LLC
To: THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 056295/0001 →
Security Interest
May 19, 2021
From: DELL PRODUCTS L.P.; EMC IP HOLDING COMPANY LLC
To: THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 056295/0124 →
Security Interest
May 19, 2021
From: DELL PRODUCTS L.P.; EMC IP HOLDING COMPANY LLC
To: THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 056295/0280 →
Release of Security Interest
Nov 2, 2021
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: DELL PRODUCTS L.P.; EMC IP HOLDING COMPANY LLC
Reel/Frame 058297/0332 →
Release of Security Interest in Patents Previously Recorded at Reel/Frame (056295/0280)
Jun 10, 2022
From: THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS NOTES COLLATERAL AGENT
To: DELL PRODUCTS L.P.; EMC IP HOLDING COMPANY LLC
Reel/Frame 062022/0255 →
Release of Security Interest in Patents Previously Recorded at Reel/Frame (056295/0001)
Jun 10, 2022
From: THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS NOTES COLLATERAL AGENT
To: DELL PRODUCTS L.P.; EMC IP HOLDING COMPANY LLC
Reel/Frame 062021/0844 →
Release of Security Interest in Patents Previously Recorded at Reel/Frame (056295/0124)
Jun 10, 2022
From: THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS NOTES COLLATERAL AGENT
To: DELL PRODUCTS L.P.; EMC IP HOLDING COMPANY LLC
Reel/Frame 062022/0012 →
Grant of Security Interest in United States Patents
Feb 12, 2024
From: ARNASI 701 LLC
To: ACP POST OAK CREDIT I LLC
Reel/Frame 066564/0727 →
Assignment of Assignor's Interest
Feb 15, 2024
From: ARREVUS, INC.
To: ARNASI 701 LLC
Reel/Frame 066457/0590 →